Clinical Trials List
2024-10-01 - 2034-06-01
Phase III
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
xxxxxx
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳尚俊 無
- 黃俊凱 無
- 廖斌志 無
- CHAO-CHI HO CHAO-CHI HO 無
- YEN-TING LIN 無
- 許嘉林 無
- 楊景堯 無
- 錢穎群 無
- Chong-Jen Yu 無
- Chia-Chi Lin 無
- 陳冠宇 無
- 廖唯昱 無
- Jih-Hsiang Lee 無
- 徐偉勛 無
- James Chih-Hsin Yang 無
- 蔡子修 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王逸熙 Division of General Internal Medicine
- 林理涵 Division of General Internal Medicine
- 陳友木 Division of General Internal Medicine
- 黃詩喻 Division of General Internal Medicine
- 李易濰 Division of General Internal Medicine
- 張晃智 Division of General Internal Medicine
- Chia-Cheng Tseng Division of General Internal Medicine
- 賴建豪 Division of General Internal Medicine
- 林孟志 Division of General Internal Medicine
- 郭明濬 Division of General Internal Medicine
- 黃國棟 Division of General Internal Medicine
- 鍾聿修 Division of General Internal Medicine
- Shau-Hsuan Li Division of General Internal Medicine
- 張育平 Division of General Internal Medicine
- 陳彥豪 Division of General Internal Medicine
- 趙東瀛 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Lu Chiang Division of Thoracic Medicine
- 趙恒勝 無
- YEN-HAN TSENG Division of Thoracic Medicine
- 廖映庭 Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
1000 participants
